Datasets
- 1 results
Search results
-
Supplementary Tables 1 and 2. A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.
Groot, J. D. (Contributor), Ott, M. (Creator), Wei, J. (Creator), Kassab, C. (Creator), Fang, D. (Creator), Najem, H. (Creator), O'Brien, B. (Contributor), Weathers, S.-P. (Creator), Majd, N. K. (Creator), Harrison, R. A. (Creator), Fuller, G. N. (Contributor), Huse, J. T. (Creator), Long, J. P. (Creator), Sawaya, R. (Creator), Rao, G. (Creator), Macdonald, T. J. (Contributor), Priebe, W. (Creator), Decuypere, M. (Contributor) & Heimberger, A. B. (Creator), Future Science Group, 2022
DOI: 10.25402/fsg.19771747.v1, https://tandf.figshare.com/articles/dataset/Supplementary_Tables_1_and_2_A_first-in-human_Phase_I_trial_of_the_oral_p-STAT3_inhibitor_WP1066_in_patients_with_recurrent_malignant_glioma_/19771747/1
Dataset